Computype, Inc. launched the Cryo Hold TS994, a label for plastic and glass labware made to withstand extreme conditions in the laboratory environment, that is suitable for flexographic imaging, thermal-transfer imaging, and automatic application.
Eli Lilly and Company announced Phase 1 data on LY2127399, a human monoclonal antibody that neutralizes B-cell activating factor (BAFF), for use in combination with bortezomib in patients with previously-treated multiple myeloma.
MorphoSys AG announced promising pre-clinical data on MOR202 a fully human anti-CD38 antibody. By combining MOR202 with two approved drugs for the treatment of multiple myeloma, the anti-cancer activity of the antibody could be enhanced.
Minors in New Jersey won't be able to get Botox injections without a doctor saying it's medically necessary under a bill moving through the Assembly.
The FBI has requested a DNA sample from "Unabomber" Ted Kaczynski as part of its investigation into the 1982 deaths of seven Chicago-area people who took cyanide-laced Tylenol from packages that had been tampered with, officials said.
A new study further validates the use of humanized BLT mice in the fight to block HIV transmission. Humanized BLT mice have a fully functioning human immune system and can be infected with HIV in the same manner as humans.
Researchers have used cells found naturally in the body, to re-educate the immune system to prevent rejection of an organ transplant while remaining capable of fighting infections and cancer.
An NIH-funded study has found that despite their beneficial effects in treating heart disease, neither aspirin nor simvastatin appear to offer benefit to patients suffering from pulmonary artery hypertension.
Research physicians believe that a new treatment regimen for patients with metastatic colon cancer appears to offer clinical benefit even when used after multiple other treatments have failed.
Quay Pharmaceuticals has invested in a variety of new equipment as part of its move to its purpose-designed facility in Deeside, U.K., which was officially opened last year.
Pharmatek Laboratories, Inc. has added spray drying to its drug formulation and manufacturing capabilities, purchasing a Buchi B-290 Mini Spray Dryer for formulation feasibility studies and small-scale clinical manufacture.
ERT has signed three contracts with pharmaceutical companies for its electronic patient reported outcomes (ePRO) business , totaling over $10 million.
DaVita Clinical Research has completed a Phase I-IIa cleanroom to comply with USP 797 high risk regulations demonstrating the cleanroom meets the requirements to handle compounds in a safe and efficient manner.
PPD, Inc. announced it has established four practice areas through PPD Consulting-biosimilars, adaptive trial design, China regulatory strategy, and cardiovascular outcomes studies.
Harman Dubé has joined Ockham as vice-president of pre-clinical and regulatory affairs within the OckhamCRO division.